Zeria Pharmaceutical Co., Ltd. (4559.T)
JPY 2454.0
(1.95%)
JPY 2454.0
(1.95%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 14.48 Billion JPY | 13.52% |
| 2022 | 12.76 Billion JPY | 6.81% |
| 2021 | 11.95 Billion JPY | 7.62% |
| 2020 | 11.1 Billion JPY | 16.11% |
| 2019 | 9.56 Billion JPY | -4.59% |
| 2018 | 10.02 Billion JPY | 6.91% |
| 2017 | 9.37 Billion JPY | 8.91% |
| 2016 | 8.6 Billion JPY | 7.43% |
| 2015 | 8.01 Billion JPY | -2.15% |
| 2014 | 8.18 Billion JPY | 5.89% |
| 2013 | 7.73 Billion JPY | 18.22% |
| 2012 | 6.54 Billion JPY | 7.81% |
| 2011 | 6.06 Billion JPY | 15.94% |
| 2010 | 5.23 Billion JPY | -15.71% |
| 2009 | 6.2 Billion JPY | 7.99% |
| 2008 | 5.74 Billion JPY | 10.34% |
| 2007 | 5.21 Billion JPY | 7.95% |
| 2006 | 4.82 Billion JPY | 26.33% |
| 2005 | 3.82 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 14.71 Billion JPY | 1.57% |
| 2023 Q4 | 14.48 Billion JPY | 0.3% |
| 2023 Q3 | 14.44 Billion JPY | 1.13% |
| 2023 Q2 | 14.28 Billion JPY | 5.51% |
| 2023 FY | 14.48 Billion JPY | 13.52% |
| 2023 Q1 | 13.53 Billion JPY | 6.07% |
| 2022 Q3 | 12.49 Billion JPY | -4.14% |
| 2022 FY | 12.76 Billion JPY | 6.81% |
| 2022 Q4 | 12.76 Billion JPY | 2.18% |
| 2022 Q1 | 12.27 Billion JPY | 2.71% |
| 2022 Q2 | 13.03 Billion JPY | 6.17% |
| 2021 Q4 | 11.95 Billion JPY | 0.61% |
| 2021 Q1 | 11.89 Billion JPY | 7.12% |
| 2021 FY | 11.95 Billion JPY | 7.62% |
| 2021 Q3 | 11.87 Billion JPY | -0.98% |
| 2021 Q2 | 11.99 Billion JPY | 0.86% |
| 2020 Q2 | 11.36 Billion JPY | 2.07% |
| 2020 Q3 | 11.3 Billion JPY | -0.56% |
| 2020 Q4 | 11.1 Billion JPY | -1.74% |
| 2020 FY | 11.1 Billion JPY | 16.11% |
| 2020 Q1 | 11.13 Billion JPY | 16.42% |
| 2019 FY | 9.56 Billion JPY | -4.59% |
| 2019 Q4 | 9.56 Billion JPY | -13.5% |
| 2019 Q3 | 11.05 Billion JPY | 0.52% |
| 2019 Q2 | 10.99 Billion JPY | 2.21% |
| 2019 Q1 | 10.76 Billion JPY | 7.35% |
| 2018 Q2 | 9.91 Billion JPY | -2.66% |
| 2018 FY | 10.02 Billion JPY | 6.91% |
| 2018 Q1 | 10.18 Billion JPY | 8.66% |
| 2018 Q3 | 10.33 Billion JPY | 4.25% |
| 2018 Q4 | 10.02 Billion JPY | -3.04% |
| 2017 Q3 | 9.76 Billion JPY | 6.08% |
| 2017 Q1 | 9.17 Billion JPY | 6.62% |
| 2017 FY | 9.37 Billion JPY | 8.91% |
| 2017 Q4 | 9.37 Billion JPY | -4.01% |
| 2017 Q2 | 9.2 Billion JPY | 0.31% |
| 2016 FY | 8.6 Billion JPY | 7.43% |
| 2016 Q2 | 8.06 Billion JPY | -2.78% |
| 2016 Q1 | 8.29 Billion JPY | 3.49% |
| 2016 Q3 | 8.41 Billion JPY | 4.39% |
| 2016 Q4 | 8.6 Billion JPY | 2.29% |
| 2015 Q1 | 8.36 Billion JPY | 2.18% |
| 2015 FY | 8.01 Billion JPY | -2.15% |
| 2015 Q4 | 8.01 Billion JPY | -4.11% |
| 2015 Q3 | 8.35 Billion JPY | -0.58% |
| 2015 Q2 | 8.4 Billion JPY | 0.45% |
| 2014 Q4 | 8.18 Billion JPY | -5.85% |
| 2014 Q2 | 8.36 Billion JPY | 1.93% |
| 2014 Q3 | 8.69 Billion JPY | 4.0% |
| 2014 FY | 8.18 Billion JPY | 5.89% |
| 2014 Q1 | 8.2 Billion JPY | 6.09% |
| 2013 FY | 7.73 Billion JPY | 18.22% |
| 2013 Q1 | 7.1 Billion JPY | 8.54% |
| 2013 Q2 | 7.36 Billion JPY | 3.73% |
| 2013 Q3 | 7.51 Billion JPY | 2.04% |
| 2013 Q4 | 7.73 Billion JPY | 2.89% |
| 2012 Q1 | 6.4 Billion JPY | 5.49% |
| 2012 FY | 6.54 Billion JPY | 7.81% |
| 2012 Q4 | 6.54 Billion JPY | 5.16% |
| 2012 Q3 | 6.22 Billion JPY | 4.52% |
| 2012 Q2 | 5.95 Billion JPY | -7.02% |
| 2011 Q1 | 5.91 Billion JPY | 13.01% |
| 2011 Q2 | 6.14 Billion JPY | 3.9% |
| 2011 Q4 | 6.06 Billion JPY | -2.48% |
| 2011 FY | 6.06 Billion JPY | 15.94% |
| 2011 Q3 | 6.22 Billion JPY | 1.25% |
| 2010 Q3 | 6.1 Billion JPY | -0.03% |
| 2010 FY | 5.23 Billion JPY | -15.71% |
| 2010 Q2 | 6.1 Billion JPY | 0.5% |
| 2010 Q1 | 6.07 Billion JPY | -2.19% |
| 2010 Q4 | 5.23 Billion JPY | -14.23% |
| 2009 Q3 | 6.51 Billion JPY | -1.8% |
| 2009 Q4 | 6.2 Billion JPY | -4.73% |
| 2009 Q2 | 6.63 Billion JPY | 0.0% |
| 2009 FY | 6.2 Billion JPY | 7.99% |
| 2008 Q3 | 6.38 Billion JPY | 0.0% |
| 2008 Q4 | 5.74 Billion JPY | -9.9% |
| 2008 FY | 5.74 Billion JPY | 10.34% |
| 2007 FY | 5.21 Billion JPY | 7.95% |
| 2006 FY | 4.82 Billion JPY | 26.33% |
| 2005 FY | 3.82 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -115.718% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 98.802% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 87.438% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 77.679% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -622.308% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 62.952% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 15.595% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 91.704% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -354.937% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 31.575% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 52.144% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | -2.026% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -35.14% |
| Tsumura & Co. | 117.61 Billion JPY | 87.68% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 44.897% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -34.889% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 85.664% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 25.199% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 72.901% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -642.303% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 30.638% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -6144.778% |
| MedRx Co., Ltd | 10 Million JPY | -144797.58% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -807.534% |
| Solasia Pharma K.K. | 122 Million JPY | -11776.851% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -227977.412% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 28.979% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 85.511% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -31368.689% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 83.4% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -539.369% |